Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by DJDawgon Aug 17, 2023 11:55am
554 Views
Post# 35593029

share activity

share activityI've always found it strange how this oscillates between 0.23 and 0.3 (lately). It is strange that there are no buyers for long stretches and then there are buyers willing to buy hundreds of thousands with the cash ready to go. I own another stock in biotech that has this pattern and it seems like whenever there is a information gap, all it takes is a sale of a larger block of shares to trigger a bit of a mass sell off (everyone fears that there is inside info that triggered the initial sell). But then there is someone(s) with ready cash to pick up large number of shares at the bottom part of that range. It seems like it could be a well played game whenever there is information void.

I stay for the science. In all of my oncology reading, I have not found any other non-surgical treatment that can cure a cancer on a single treatment the way Ruvidar did for those phase 1b, worst of the worst, patients. Most of them seem to be stuck in an endless cycle of IV infusions of immune agents which hold cancer at bay but don't cure.

And so we wait. However painful it is. I see that Aug 29 is the next filing and they usually give swimmers plot  update then. 12 more days of wondering if there is anything new is not as bad as waiting months I guess.

<< Previous
Bullboard Posts
Next >>